SANA Stock Summary and Trading Ideas (Sana Biotechnology | NASDAQ:SANA)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Sana Biotechnology trades on the NASDAQ stock market under the symbol SANA.

As of January 23, 2026, SANA stock price declined to $4.83 with 2,038,655 million shares trading.

SANA has a beta of 1.94, meaning it tends to be more sensitive to market movements. SANA has a correlation of 0.12 to the broad based SPY ETF.

SANA has a market cap of $1.23 billion. This is considered a Small Cap stock.

In the last 3 years, SANA traded as high as $12.00 and as low as $1.26.

The top ETF exchange traded funds that SANA belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWN.

SANA has outperformed the market in the last year with a price return of +38.0% while the SPY ETF gained +14.9%. However, in the short term, SANA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -12.2% vs +3.5% return in SPY. But in the last 2 weeks, SANA shares have fared better than the market returning +6.9% compared to SPY 0.0%.

SANA support price is $4.80 and resistance is $5.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SANA shares will trade within this expected range on the day.